SOBR Safe, Inc. — Director's Dealing 2020

Jan 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransBiotec, Inc. (IMLE)
CIK: 0001425627
Period of Report: 2019-10-25

Reporting Person: Gandini David Joseph (Director, Chief Revenue Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-25	Common Stock Option	$0.0079	A	8000000	Acquired	2029-10-31	Common Stock (8000000)	Direct
2019-10-25	Common Stock Option	$0.0079	A	24000000	Acquired	2029-11-25	Common Stock (24000000)	Direct

Footnotes

F1: Pursuant to the Reporting Person's Employment Agreement as the Issuer's Chief Revenue Officer, the Reporting Person was issued a stock option to acquire 8,000,000 shares of the Issuer's common stock at $0.00792 per share, with 6,666,600 options vesting on October 31, 2019 and 1,333,400 options vesting on December 31, 2019. The options expire 10 years after vesting.

F2: Pursuant to the Reporting Person's Employment Agreement, the Reporting Person was issued a stock option to acquire 24,000,000 shares of the Issuer's common stock at an exercise price of $0.00792 per share. The shares vest in equal monthly installments of 666,666 shares per month over 36 months and expire ten years from the vesting date.